Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
出版年份 2022 全文链接
标题
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
作者
关键词
-
出版物
JAMA Neurology
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2022-12-13
DOI
10.1001/jamaneurol.2022.4485
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Associating Alzheimer’s disease pathology with its cerebrospinal fluid biomarkers
- (2022) Claire Bridel et al. BRAIN
- Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
- (2022) Nicholas J. Ashton et al. EBioMedicine
- Performance of plasma phosphorylated tau 181 and 217 in the community
- (2022) Michelle M. Mielke et al. NATURE MEDICINE
- Staging of Alzheimer’s disease: past, present, and future perspectives
- (2022) Joseph Therriault et al. TRENDS IN MOLECULAR MEDICINE
- Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
- (2022) Colin Groot et al. BRAIN
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
- (2021) Yang Shi et al. ACTA NEUROPATHOLOGICA
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
- (2021) Niklas Mattsson‐Carlgren et al. EMBO Molecular Medicine
- A current view on Tau protein phosphorylation in Alzheimer's disease
- (2021) Susanne Wegmann et al. CURRENT OPINION IN NEUROBIOLOGY
- Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
- (2021) Rik Ossenkoppele et al. EMBO Molecular Medicine
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
- (2021) Michelle M. Mielke et al. JAMA Neurology
- P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
- (2021) Juan Lantero‐Rodriguez et al. EMBO Molecular Medicine
- β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade
- (2020) Fang Zhang et al. Science Translational Medicine
- Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography
- (2020) Pierre-François Meyer et al. JAMA Neurology
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- The implications of different approaches to define AT(N) in Alzheimer disease
- (2020) Niklas Mattsson-Carlgren et al. NEUROLOGY
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
- (2020) Antoinette O’Connor et al. MOLECULAR PSYCHIATRY
- Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
- (2020) Simon Dujardin et al. NATURE MEDICINE
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
- (2019) Suzanne E. Schindler et al. Alzheimers & Dementia
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
- (2019) Anuradha Venkatramani et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
- (2019) Joseph Therriault et al. JAMA Neurology
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
- (2018) Victor L. Villemagne et al. Nature Reviews Neurology
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
- (2018) Yakeel T. Quiroz et al. JAMA Neurology
- Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
- (2018) Jian-Zhi Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- The impact of Aβ and tau on prospective cognitive decline in older individuals
- (2018) Reisa A. Sperling et al. ANNALS OF NEUROLOGY
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- cocor: A Comprehensive Solution for the Statistical Comparison of Correlations
- (2015) Birk Diedenhofen et al. PLoS One
- A three-dimensional human neural cell culture model of Alzheimer’s disease
- (2014) Se Hoon Choi et al. NATURE
- Changes in Amyloid- and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- (2013) L. F. Maia et al. Science Translational Medicine
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started